Skip to main content
. 2017 Jul 20;6(10):e1353856. doi: 10.1080/2162402X.2017.1353856

Figure 3.

Figure 3.

ILT2 expression correlates with cytogenetic abnormalities that are markers of the progression of the disease. (A) Comparison between ILT2+ CD8 T cells, ILT2+ CD4 T cells, and ILT2+ B cells from CLL patients stratified by the presence of chromosome 11q deletion. Horizontal bars represent the mean ± SEM. (B) The comparison between ILT2+ CD4 T cells, ILT2+ CD8 T cells and ILT2+ B cells from CLL patients with or without chromosome 13q deletion is shown.